Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review

Background Hospitalized patients with coronavirus disease 2019 (COVID-19) infection have higher rates of venous thromboembolism (VTE).Higher mortality rates have been reported in severe cases of COVID-19 including those who have elevated D-dimer levels and have thromboembolic phenomena. Objective Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrillo, Alessandra, Punatar, Shil, Pavaluri, Sushma, Jentink, Madeline, Patel, Dixita, Braun, Joseph, Todorova, Tsvetelina, Safarpour, Damoun, Farooqui, Marwah W, Ghouse, Masood, Srinivasan, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
332.Anticoagulation and Antithrombotic Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701428/
http://dx.doi.org/10.1182/blood-2021-145633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701428/
http://dx.doi.org/10.1182/blood-2021-145633

Ejemplares similares